These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Modified human immune serum globulin for intravenous administration: in vitro opsonic activity and in vivo protection against group B streptococcal disease in suckling rats. Fischer GW, Hunter KW, Wilson SR. Acta Paediatr Scand; 1982 Jul; 71(4):639-44. PubMed ID: 6753478 [Abstract] [Full Text] [Related]
4. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models. Givner LB. Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536 [Abstract] [Full Text] [Related]
5. The role of specific antibody in neonatal bacterial infections: an overview. Anthony BF. Pediatr Infect Dis; 1986 Dec; 5(3 Suppl):S164-7. PubMed ID: 3520499 [Abstract] [Full Text] [Related]
6. Efficacy of human immunoglobulin and penicillin G in treatment of experimental group B streptococcal infection. Kim KS. Pediatr Res; 1987 Mar; 21(3):289-92. PubMed ID: 3550675 [Abstract] [Full Text] [Related]
7. Demonstration of opsonic and protective activity of human cord sera against type III group B streptococcus that are independent of type-specific antibody. Kim KS, Wass CA, Hong JK, Concepcion NF, Anthony BF. Pediatr Res; 1988 Nov; 24(5):628-32. PubMed ID: 3060825 [Abstract] [Full Text] [Related]
8. Murine hybridoma antibodies enhance bactericidal activity of human cord blood against K1 Escherichia coli strains. Kim KS, Cross AS, Kaufmann B, Zollinger W, Sadoff J. Pediatr Res; 1990 Dec; 28(6):667-70. PubMed ID: 1704500 [Abstract] [Full Text] [Related]
9. Polyvalent group B streptococcal immune globulin for intravenous administration: overview. Fischer GW, Hemming VG, Gloser HP, Bachmayer H, von Pilar CE, Wilson SR, Baron PA. Rev Infect Dis; 1990 Dec; 12 Suppl 4():S483-9; discussion S489-91. PubMed ID: 2194273 [Abstract] [Full Text] [Related]
10. Protective efficacy of a modified immune serum globulin in experimental group B streptococcal infection. Santos JI, Shigeoka AO, Rote NS, Hill HR. J Pediatr; 1981 Dec; 99(6):873-9. PubMed ID: 7031210 [Abstract] [Full Text] [Related]
11. Intravenous immunoglobulin in the treatment of neonatal sepsis: therapeutic strategies and laboratory studies. Fischer GW, Hemming VG, Hunter KW, Gloser H, Bachmayer H, Von Pilar CE, Helting T, Weisman LE, Wilson SR, Baron PA. Pediatr Infect Dis; 1986 Dec; 5(3 Suppl):S171-5. PubMed ID: 3520501 [Abstract] [Full Text] [Related]
12. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci. Fischer GW, Wilson SR, Hunter KW. J Clin Immunol; 1982 Apr; 2(2 Suppl):31S-35S. PubMed ID: 7045156 [Abstract] [Full Text] [Related]
13. Comparative opsonic activity of intravenous gamma globulin preparations for common bacterial pathogens. Hill HR, Augustine NH, Shigeoka AO. Am J Med; 1984 Mar 30; 76(3A):61-6. PubMed ID: 6424458 [Abstract] [Full Text] [Related]
14. Transplacental or enteral transfer of maternal immunization-induced antibody protects suckling rats from type III group B streptococcal infection. Heiman HS, Weisman LE. Pediatr Res; 1989 Dec 30; 26(6):629-32. PubMed ID: 2689988 [Abstract] [Full Text] [Related]
15. Comparison of the opsonic and complement triggering activity of human monoclonal IgG1 and IgM antibody against group B streptococci. Shyur SD, Raff HV, Bohnsack JF, Kelsey DK, Hill HR. J Immunol; 1992 Mar 15; 148(6):1879-84. PubMed ID: 1541826 [Abstract] [Full Text] [Related]
16. Opsonic activity of serum and whey from cows immunized with the ferric citrate receptor. Wise AJ, Hogan JS, Takemura K, Smith KL. J Dairy Sci; 2003 Jan 15; 86(1):146-51. PubMed ID: 12613859 [Abstract] [Full Text] [Related]